Interaction Checker
Potential Weak Interaction
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Tacrolimus
Quality of Evidence: Low
Summary:
There was no clinically significant pharmacokinetic interaction when emtricitabine/tenofovir-DF was coadministered with tacrolimus. Coadministration increased tacrolimus AUC and Cmax by 4% and 3%; emtricitabine AUC and Cmax decreased by 5% and 11%, but tenofovir AUC and Cmax increased by 6% and 13%. No dose adjustment of tacrolimus is required but monitor renal function as appropriate since tacrolimus can affect renal function.
Description:
View all available interactions with Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking here.
No Version Present
Copyright © 2024 The University of Liverpool. All rights reserved.